Long-Term Outcomes of BMMSC Compared with BMMNC for Treatment of Critical Limb Ischemia and Foot Ulcer in Patients with Diabetes

We first compared long-term clinical outcomes in treating critical limb ischemia (CLI) and foot ulcer in patients with diabetes between autologous bone marrow mesenchymal stem cell (BMMSC) and bone-marrow-derived mononuclear cell (BMMNC) transplants. Forty-one patients were enrolled and followed up...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Debin, Jiang, Youzhao, Deng, Wuquan, Zhang, Yan, Liang, Ziwen, Wu, Qinan, Jiang, Xiaoyan, Zhang, Ling, Gao, Fang, Cao, Ying, Chen, Bing, Xue, Yaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103602/
https://www.ncbi.nlm.nih.gov/pubmed/30917698
http://dx.doi.org/10.1177/0963689719835177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103602/
https://www.ncbi.nlm.nih.gov/pubmed/30917698
http://dx.doi.org/10.1177/0963689719835177

Ejemplares similares